PA8772401A1 - Macrólidos - Google Patents

Macrólidos

Info

Publication number
PA8772401A1
PA8772401A1 PA20088772401A PA8772401A PA8772401A1 PA 8772401 A1 PA8772401 A1 PA 8772401A1 PA 20088772401 A PA20088772401 A PA 20088772401A PA 8772401 A PA8772401 A PA 8772401A PA 8772401 A1 PA8772401 A1 PA 8772401A1
Authority
PA
Panama
Prior art keywords
macrolids
refers
formula compounds
procedures
document
Prior art date
Application number
PA20088772401A
Other languages
English (en)
Inventor
Bryan Li Zhengong
Victor Magee Thomas
Edward Flanagan Mark
Carl Noe Mark
Allen Buzon Richard
William Widlicka Daniel
Datta Reilly Usa
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8772401A1 publication Critical patent/PA8772401A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (1) EN LA QUE R1, R2,Y X SON COMO SE DEFINEN EL EL PRESENTE DOCUMENTO. LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS Y PROCEDIMIENTOS DE TRATAMIENTO DE INFECCIONES BACTERIANAS USANDO LOS COMPUESTOS DE FORMULA (1).
PA20088772401A 2007-03-13 2008-03-13 Macrólidos PA8772401A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89447507P 2007-03-13 2007-03-13
US2337008P 2008-01-24 2008-01-24

Publications (1)

Publication Number Publication Date
PA8772401A1 true PA8772401A1 (es) 2008-11-19

Family

ID=39760163

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088772401A PA8772401A1 (es) 2007-03-13 2008-03-13 Macrólidos

Country Status (28)

Country Link
US (1) US20080293646A1 (es)
EP (1) EP2125851B1 (es)
JP (1) JP4468487B1 (es)
KR (1) KR20090110381A (es)
CN (1) CN101631795A (es)
AP (1) AP2009004985A0 (es)
AR (1) AR065724A1 (es)
AT (1) ATE471943T1 (es)
AU (1) AU2008224633A1 (es)
BR (1) BRPI0809002A2 (es)
CA (1) CA2680527A1 (es)
CL (1) CL2008000695A1 (es)
CR (1) CR10998A (es)
CU (1) CU20090155A7 (es)
DE (1) DE602008001611D1 (es)
DO (1) DOP2009000214A (es)
EA (1) EA200901059A1 (es)
EC (1) ECSP099627A (es)
IL (1) IL200613A0 (es)
MA (1) MA31252B1 (es)
MX (1) MX2009009074A (es)
PA (1) PA8772401A1 (es)
PE (1) PE20090106A1 (es)
SV (1) SV2009003368A (es)
TN (1) TN2009000374A1 (es)
TW (1) TW200848061A (es)
UY (1) UY30957A1 (es)
WO (1) WO2008110918A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2822953T (lt) * 2012-03-06 2017-04-10 Pfizer Inc. Makrocikliniai dariniai, skirti proliferacinių ligų gydymui
US9982005B2 (en) 2013-04-04 2018-05-29 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
WO2016057798A1 (en) * 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
CN107530365A (zh) 2015-03-25 2018-01-02 哈佛大学的校长及成员们 具有修饰的脱氧糖胺糖的大环内酯及其用途
CN105924451B (zh) * 2016-04-27 2017-12-15 国家海洋局第三海洋研究所 具有抗茶叶致病真菌活性的大环内酯化合物及制备与用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1836211B1 (en) * 2004-12-21 2010-03-03 Pfizer Products Inc. Macrolides

Also Published As

Publication number Publication date
CR10998A (es) 2009-09-11
US20080293646A1 (en) 2008-11-27
ATE471943T1 (de) 2010-07-15
CA2680527A1 (en) 2008-09-18
EA200901059A1 (ru) 2010-02-26
EP2125851A2 (en) 2009-12-02
AU2008224633A1 (en) 2008-09-18
UY30957A1 (es) 2008-10-31
WO2008110918A3 (en) 2009-01-29
MA31252B1 (fr) 2010-03-01
EP2125851B1 (en) 2010-06-23
AR065724A1 (es) 2009-06-24
IL200613A0 (en) 2010-05-17
ECSP099627A (es) 2009-10-30
SV2009003368A (es) 2009-11-09
JP2010521448A (ja) 2010-06-24
CN101631795A (zh) 2010-01-20
CL2008000695A1 (es) 2008-09-22
CU20090155A7 (es) 2011-04-26
BRPI0809002A2 (pt) 2014-11-11
WO2008110918A2 (en) 2008-09-18
DE602008001611D1 (en) 2010-08-05
TW200848061A (en) 2008-12-16
TN2009000374A1 (fr) 2010-12-31
JP4468487B1 (ja) 2010-05-26
PE20090106A1 (es) 2009-02-08
DOP2009000214A (es) 2009-10-31
KR20090110381A (ko) 2009-10-21
MX2009009074A (es) 2009-09-28
AP2009004985A0 (en) 2009-10-31

Similar Documents

Publication Publication Date Title
PA8855001A1 (es) Monocarbamas
ECSP10010722A (es) Compuestos orgánicos
GT200800170A (es) Compuestos de n-formil-hidroxilamina
PA8809001A1 (es) Compuestos organicos
UY30789A1 (es) Derivados de adenina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
UY32730A (es) Inhibidores de cyp17
ECSP11010804A (es) Compuestos orgánicos
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
UY32543A (es) Análogos de isoxazol-3(2h)-ona como agentes terapéuticos
PA8777101A1 (es) Derivados de sulfonil amida para el tratamiento del crecimiento celular anormal
CL2011001295A1 (es) Compuestos derivados de 1h-pirazol-4-carboxamida; metodo de control o prevencion de una infestacion de plantas utiles por microorganismos fitopatogenos; composicion pesticida que comprende a dichos compuestos.
NI201000164A (es) Hidroximetil pirrolidinas como agonistas del receptor adrenérgico beta 3.
ECSP11010760A (es) Derivados de quinoxalindiona
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
UY29486A1 (es) Compuestos utiles en terapia
GT200800187A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
GT200900309A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
CO6382123A2 (es) Antagonistas de la via hedgehog de ftalazina disustituida
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
UY31138A1 (es) Derivados de indolinonas sustituidas, composiciones conteniendolos y aplicaciones
GT200500308A (es) Nonadepsipeptidos acilados ii
PA8772401A1 (es) Macrólidos
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan